Trending Topic

bullous pemphigoid
2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

    The FDA approval of dupilumab represents a major step forward for adults living with bullous pemphigoid (BP), one that is likely to transform how we manage this chronic autoimmune blistering condition. Dupilumab, a monoclonal antibody that blocks IL-4Rα and inhibits IL-4 and IL-13 signalling, is the first targeted therapy approved for bullous pemphigoid. […]

Teledermatology

An Introduction to Teledermatology

Mark CompleteCompleted
BookmarkBookmarked

This year, we are celebrating our inaugural touchDERMATOLOGY Future Leaders to recognize the outstanding talent that has entered our field in recent years. These individuals are set to innovate and transform dermatology in the years to come. Representing a diverse range of expertise from across the globe, these highly accomplished clinicians are among the brightest minds shaping the future of dermatology. We had the pleasure of learning about their unique career journeys, motivations, and the inspirations that have guided their paths. They also shared their perspectives on the most exciting developments in dermatology today, along with their hopes for the future of the field. Congratulations to all our touchDERMATOLOGY Future Leaders, and thank you for sharing your stories, insights and ambitions with us.

Mark CompleteCompleted
BookmarkBookmarked

Dr Niraj Parajuli shares his journey into dermatology, from early motivations to his current work in neglected tropical diseases, rare skin conditions, and digital dermatology. Discover how his global leadership and commitment to health equity are shaping the future of the field.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

Mark CompleteCompleted
BookmarkBookmarked

We are delighted to welcome Dr Benjamin Kaffenberger, Associate Professor of Dermatology at The Ohio State University Wexner Medical Center, to the touchDERMATOLOGY Expert Faculty. A leading expert in complex skin conditions such as pyoderma gangrenosum, DRESS syndrome, and SJS/TEN, Kaffenberger brings extensive clinical and research experience in drug reactions, wound care, and hospital dermatology.

Mark CompleteCompleted
BookmarkBookmarked

As 2025 unfolds, the field of dermatology is set for some significant advancements. To get a glimpse of what’s ahead, we turned to our esteemed Expert Faculty members, who shared their expert insights on what they think will be the key innovations shaping this year. From the most exciting trends of 2024 that are gaining momentum to the next breakthroughs poised to redefine patient care, here’s what they had to say.

Close Popup